{"id":"https://openalex.org/W4361886355","doi":"https://doi.org/10.1158/1078-0432.22465556","title":"Figure S2 from Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer","display_name":"Figure S2 from Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361886355","doi":"https://doi.org/10.1158/1078-0432.22465556"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22465556","doi":"https://doi.org/10.1158/1078-0432.22465556","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22465556","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22465556","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032545251","display_name":"Adam J. Camblin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam J. Camblin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833343","display_name":"Emily A. Pace","orcid":"https://orcid.org/0009-0006-0244-3456","observed_orcids":["https://orcid.org/0009-0006-0244-3456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily A. Pace","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083052847","display_name":"Sharlene Adams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharlene Adams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110211","display_name":"Michael D. Curley","orcid":"https://orcid.org/0009-0003-6621-4327","observed_orcids":["https://orcid.org/0009-0003-6621-4327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D. Curley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074475804","display_name":"Victoria M. Rimkunas","orcid":"https://orcid.org/0000-0003-4263-2009","observed_orcids":["https://orcid.org/0000-0003-4263-2009"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victoria Rimkunas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100533073","display_name":"Lin Nie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Nie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069091223","display_name":"Gege Tan","orcid":"https://orcid.org/0009-0005-6888-6500","observed_orcids":["https://orcid.org/0009-0005-6888-6500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gege Tan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007255501","display_name":"Troy Bloom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Troy Bloom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017341589","display_name":"Sergio Iadevaia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sergio Iadevaia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076139382","display_name":"Jason Baum","orcid":"https://orcid.org/0000-0002-4417-4980","observed_orcids":["https://orcid.org/0000-0002-4417-4980"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Baum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054245166","display_name":"Charlene Minx","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charlene Minx","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050035884","display_name":"Akos Gabor Czibere","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akos Czibere","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112204034","display_name":"Chrystal Ursula Louis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chrystal U. Louis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008160506","display_name":"Daryl C. Drummond","orcid":"https://orcid.org/0000-0001-6803-8863","observed_orcids":["https://orcid.org/0000-0001-6803-8863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daryl C. Drummond","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074616498","display_name":"Ulrik B. Nielsen","orcid":"https://orcid.org/0000-0001-7198-1924","observed_orcids":["https://orcid.org/0000-0001-7198-1924"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ulrik B. Nielsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087864188","display_name":"Birgit Schoeberl","orcid":"https://orcid.org/0000-0002-1990-5315","observed_orcids":["https://orcid.org/0000-0002-1990-5315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Birgit Schoeberl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086314355","display_name":"J. Marc Pipas","orcid":"https://orcid.org/0009-0005-9972-5451","observed_orcids":["https://orcid.org/0009-0005-9972-5451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Marc Pipas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057883761","display_name":"Robert M. Straubinger","orcid":"https://orcid.org/0000-0003-0870-9236","observed_orcids":["https://orcid.org/0000-0003-0870-9236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M. Straubinger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0870-9236","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020173185","display_name":"Vasileios Askoxylakis","orcid":"https://orcid.org/0000-0002-2594-3019","observed_orcids":["https://orcid.org/0000-0002-2594-3019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vasileios Askoxylakis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113792277","display_name":"Alexey A. Lugovskoy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexey A. Lugovskoy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf1r-inhibition","display_name":"IGF1R inhibition","score":0.8500000238418579},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.8479999899864197},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9129999876022339},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9919999837875366},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/growth-factor-signaling","display_name":"growth factor signaling","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9391657114028931},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8057374954223633},{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.7178337574005127},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6560600399971008},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.6176766157150269},{"id":"https://openalex.org/C2910430875","wikidata":"https://www.wikidata.org/wiki/Q7251413","display_name":"Nab-paclitaxel","level":4,"score":0.4340585470199585},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43167683482170105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41868460178375244},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40825119614601135},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3250778317451477},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.08408248424530029},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22465556","doi":"https://doi.org/10.1158/1078-0432.22465556","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22465556","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22465556","doi":"https://doi.org/10.1158/1078-0432.22465556","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22465556","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2052188532","https://openalex.org/W4387660185","https://openalex.org/W2126322332","https://openalex.org/W4205828341","https://openalex.org/W3031675857","https://openalex.org/W2596055884","https://openalex.org/W2885862304","https://openalex.org/W3031244932","https://openalex.org/W4281720666","https://openalex.org/W1965851372"],"abstract_inverted_index":{"Supplemental":[0],"Figure":[1],"S2:":[2],"Istiratumab":[3],"inhibits":[4],"growth":[5],"factor-induced":[6],"AKT":[7],"phosphorylation":[8],"across":[9],"a":[10],"pancreatic":[11],"cancer":[12],"cell":[13],"line":[14],"panel.":[15]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}
